Lescol and Demerol drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Lescol (fluvastatin sodium) and Demerol (meperidine hydrochloride). Common drug interactions include ascites among females and back pain among males.

The phase IV clinical study analyzes what interactions people have when they take Lescol and Demerol. It is created by eHealthMe based on reports of 18 people who take the same drugs from the FDA, and is updated regularly.

What is Lescol?

Lescol has active ingredients of fluvastatin sodium. It is often used in high blood cholesterol. eHealthMe is studying from 7,306 Lescol users. Check the latest studies of Lescol.

What is Demerol?

Demerol has active ingredients of meperidine hydrochloride. It is often used in pain. eHealthMe is studying from 12,706 Demerol users. Check the latest studies of Demerol.



On Jul, 18, 2026

18 people who take Lescol and Demerol together, and have interactions are studied.

Lescol and Demerol drug interactions.

What are the common drug interactions of Lescol and Demerol, by gender? *:

female:

  1. Ascites (accumulation of fluid in the abdominal cavity)
  2. Bronchitis (inflammation of the mucous membrane in the bronchial tubes)
  3. Cardiac disorder
  4. Cerebral atrophy (decrement in size of brain)
  5. Chest pain
  6. Cholelithiasis (the presence or formation of gallstones in the gallbladder or bile ducts)
  7. Deep vein thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis)
  8. Diabetes mellitus (diabetes, caused by a deficiency of the pancreatic hormone insulin)
  9. Diplopia (double vision)
  10. Drug hypersensitivity

male:

  1. Back pain
  2. Chest pain
  3. Arthralgia (joint pain)
  4. Atelectasis (partial or complete collapse of the lung)
  5. Blindness
  6. Blood creatine phosphokinase increased
  7. Blood immunoglobulin a increased
  8. Bone cyst
  9. Bone disorder
  10. Bronchitis (inflammation of the mucous membrane in the bronchial tubes)

What are the common drug interactions of Lescol and Demerol, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

  1. Abdominal distension
  2. Abdominal pain upper
  3. Anaemia (lack of blood)
  4. Anasarca (general swelling, or massive oedema)
  5. Arthritis (form of joint disorder that involves inflammation of one or more joints)
  6. Ascites (accumulation of fluid in the abdominal cavity)
  7. Blood pressure increased
  8. Carbohydrate antigen 125 increased
  9. Cardiac disorder
  10. Cardiac murmur (an heart sound in valve abnormality)

50-59:

  1. Pain in extremity
  2. Paraesthesia (sensation of tingling, tickling, prickling, pricking, or burning of a person's skin with no apparent long-term physical effect)
  3. Abdominal distension
  4. Abdominal pain
  5. Actinic keratosis (skin disease due to sun exposure)
  6. Acute sinusitis
  7. Adrenal mass
  8. Agitation (state of anxiety or nervous excitement)
  9. Angiopathy (generic term for a disease of the blood vessels)
  10. Anhedonia (inability to experience pleasure from activities usually found enjoyable)

60+:

  1. Back pain
  2. Bronchitis (inflammation of the mucous membrane in the bronchial tubes)
  3. Angiopathy (generic term for a disease of the blood vessels)
  4. Anhedonia (inability to experience pleasure from activities usually found enjoyable)
  5. Anxiety
  6. Arthralgia (joint pain)
  7. Atelectasis (partial or complete collapse of the lung)
  8. Blood creatine phosphokinase increased
  9. Blood immunoglobulin a increased
  10. Bone cyst

What are the existing conditions these people have? *

  1. Arthritis (form of joint disorder that involves inflammation of one or more joints): 7 people, 38.89%
  2. Swelling: 4 people, 22.22%
  3. High Blood Pressure: 4 people, 22.22%
  4. Pneumonia: 3 people, 16.67%
  5. Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 3 people, 16.67%
  6. Lipids Increased (excess lipid in body): 3 people, 16.67%
  7. Neuropathy Peripheral (surface nerve damage): 3 people, 16.67%
  8. Pain In Extremity: 3 people, 16.67%
  9. Diabetes: 3 people, 16.67%
  10. Depression: 3 people, 16.67%

* Approximation only. Some reports may have incomplete information.

Do you take Lescol and Demerol?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Lescol and Demerol:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Lescol:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Demerol:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Lescol and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Demerol and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on fluvastatin sodium and meperidine hydrochloride (the active ingredients of Lescol and Demerol, respectively), and Lescol and Demerol (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: